Bristol-Myers Squibb – UCLA Lectureship

When
Thu, May 12 5:00pm
Where
Cram Conference Room – 3440 Molecular Sciences Bldg
Speaker Professor Mo Movassaghi
Hosted by
UCLA Department of Chemistry and Biochemistry
Description

The 2016 Bristol-Myers Squibb – UCLA Lectureship

 

1:30 PM Lecture

“Discovery and Development of a Stereoselective Synthesis of BMS-986001: A Nucleoside Reverse Transcriptase Inhibitor (NRTI) for the Treatment of HIV Infection”

Dr. Chris Sfouggatakis

Principal Scientist, Process Development

Bristol-Myers Squibb Co.

 

– and –

 

5:00 PM Lecture

“Complex Alkaloid Total Synthesis”

Professor Mo Movassaghi

Department of Chemistry

Massachusetts Institute of Technology

Abstract.  Several representative enantioselective alkaloid total syntheses and related methodologies will be discussed. The focus of this research program is the development of new synthetic strategies for rapid generation of molecular complexity guided by biogenetic considerations. These syntheses feature new stereo- and chemoselective reactions that enable maximum use of the inherent chemistry of key intermediates. Examples involving strategic C–H functionalization in complex settings will be discussed.

 

Thursday, May 12, 2016

Cram Conference Room – 3440 Molecular Sciences Bldg

 

Attachments